Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

January 29, 2024

Study Completion Date

January 29, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

CC-97489

Specified dose on specified days

DRUG

[18F]T-401

Specified dose on specified days

DRUG

[11C]MK-3168

Specified dose on specified days

Trial Locations (1)

3000

Local Institution - 001, Leuven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY